Controversy over Depo-Provera.
D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D004194:Disease; D005193:Family Planning Services; D006077:Government Agencies; D007267:Injections; D017258:Medroxyprogesterone Acetate; D009369:Neoplasms; D009656:North America; D009938:Organizations; D010820:Physicians; D014481:United States; D002583:Uterine Cervical Neoplasms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Cancer; Cervical Cancer; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Depo-provera--side effects; Developed Countries; Diseases; Family Planning; Government Agencies; Injectables; Medroxyprogesterone Acetate--side effects; Neoplasms; North America; Northern America; Organizations; Physicians; United States